Guifang Lu

机构：First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0001-9142-2900

发表论文 42 篇 · 总被引 944 次 · h-index 18

代表论文

• An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis (2023 · ACS Nano · 被引 160)
• Yeast-Inspired Orally-Administered Nanocomposite Scavenges Oxidative Stress and Restores Gut Immune Homeostasis for Inflammatory Bowel Disease Treatment (2025 · ACS Nano · 被引 50)
• Delphinidin modulates JAK/STAT3 and MAPKinase signaling to induce apoptosis in HCT116 cells (2021 · Environmental Toxicology · 被引 43)
• Effect of intestinal microbiota transplantation on cerebral ischemia reperfusion injury in aged mice via inhibition of IL‐17 (2022 · Neurogastroenterology & Motility · 被引 24)
• The clinicopathological characteristics of gastric cancer and precancerous conditions in gastric DLBCL and MALT lymphoma patients: a multi-center retrospective study (2023 · Annals of Medicine · 被引 22)
• Screening value for gastrointestinal lesions of magnetic‐controlled capsule endoscopy in asymptomatic individuals (2020 · Journal of Gastroenterology and Hepatology · 被引 21)